Craig A Tooman insider trades

Open-market stock purchases and sales by Craig A Tooman, President and CEO at Silence Therapeutics plc, from SEC Form 4 filings since Jan 5, 2010.

Recent trades

No open-market trades in the last 12 months.

Companies traded

  • SLN Silence Therapeutics plc: other filings, last Jan 2, 2025
  • PETX Aratana Therapeutics, Inc: 5 sales, last Jul 18, 2019
  • INSV Insite Vision Inc: other filings, last Nov 2, 2015
  • ENZN Enzon Pharmaceuticals Inc: 2 sales, last Jun 18, 2010

Get free alerts when Craig A Tooman files a new trade →